Fundraising Fox

Biotech Series B Investors & VC Firms

900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.

Cantos Ventures
San FranciscoPre-Seed–Series B$400K – $1.5M
4 people
FREEFLOW
BerkeleyPre-Seed–Series B
10 people
Partnership Fund for NYC
New York CitySeed–Growth
13 people
Capital Cell
BarcelonaPre-Seed–Growth
Kernel Capital
CorkSeed–Late Stage$1.1M – $5.4M
9 people
Fund+
LeuvenSeries A–Series B$5.5M – $16.5M
11 people
Innovation Fund sa/nv
SchaerbeekSeed–Series B$270K – $2.7M
17 people
Life Sciences Greenhouse Investments
HarrisburgPre-Seed–Series B$250K – $500K
11 people
SCP Vitalife Partners
Tel AvivSeed–Late Stage$3M – $7M
11 people
Maxpro Ventures
TaipeiSeed–Late Stage$10M – $13M
7 people
Delta Partners
DublinPre-Seed–Series B$108K – $3.2M
6 people
Northern Gritstone
Pre-Seed–Growth
6 people
Oyster Bay Venture Capital
BerlinPre-Seed–Series B$1M – $5M
11 people
Clay Capital
Seed–Late Stage$3M – $8M
16 people
New Rhein Healthcare Investors, LLC
PhiladelphiaSeries A–Late Stage
15 people
Kelvin Capital
GlasgowSeed–Late Stage
8 people
AMR Action Fund
BostonSeed–Series C
13 people
Export and Investment Fund
CopenhagenPre-Seed–Growth$108K – $7.6M
16 people
Scion Life Sciences
New YorkPre-Seed–Late Stage$1K – $60M
13 people
Seroba Life Sciences
DublinSeed–Late Stage$540K – $7.6M
13 people
Riverfront Ventures, LLC
PittsburghSeed–Series B$250K – $1M
9 people
Fountain Healthcare Partners
DublinSeed–Series B$10.8M – $16.2M
8 people
Quadrille Capital
ParisSeed–Late Stage
17 people
Tullis Health Investors
Palm Beach GardensSeries A–Late Stage$500K – $10M
11 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.